Literature DB >> 22236109

Neonatal treatment with a pegylated leptin antagonist has a sexually dimorphic effect on hypothalamic trophic factors and neuropeptide levels.

V Mela1, F Díaz, A Gertler, G Solomon, J Argente, M-P Viveros, J A Chowen.   

Abstract

It is clear that the prenatal and early neonatal environments are important for determining the metabolic equilibrium in the adult animal, with prenatal/neonatal leptin levels being at least one of the factors involved. Leptin modulates hypothalamic development and, in particular, the neuronal circuits involved in metabolic control. We have recently reported that maternal deprivation (MD) for 24 h on postnatal day (PND) 9 modifies trophic factors and markers of cell turnover and neuronal maturation in the hypothalamus, as well as body weight and circulating leptin levels at PND13, with long- term effects on weight gain and circulating metabolic hormones in the adult. Moreover, these responses are sexually dimorphic. During MD, a dramatic decline in leptin levels is observed; thus, we aimed to determine which of the previously observed changes in markers of hypothalamic development might be attributed to the decline in this metabolic signal. Accordingly, male and female rats were treated with a pegylated leptin antagonist on PND9. In both sexes, hypothalamic signal transducer and activator of transcription 3 activation in response to acute leptin treatment was blocked by the antagonist. In females, hypothalamic mRNA levels for brain-derived neurotrophic factor, cocaine- and amphetamine-regulated transcript and the leptin receptor were increased, as were nestin and vimentin levels. There was also an increase in cell death in the hypothalamus, with a shift towards an anti-apoptotic balance in the Bcl2/BAX ratio. No hypothalamic effects were seen in males. Because antagonism of the actions of leptin at this specific neonatal stage affects hypothalamic cell turnover and maturation in a sex-specific manner, changes in this hormone, at least at this postnatal age, may differentially affect hypothalamic development in males and females, and may explain some of the reported sexually dimorphic responses to modifications in the early nutritional environment.
© 2012 The Authors. Journal of Neuroendocrinology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22236109     DOI: 10.1111/j.1365-2826.2012.02279.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  5 in total

1.  Early leptin intervention reverses perturbed energy balance regulating hypothalamic neuropeptides in the pre- and postnatal calorie-restricted female rat offspring.

Authors:  Leena Caroline Gibson; Bo-Chul Shin; Yun Dai; William Freije; Sudatip Kositamongkol; John Cho; Sherin U Devaskar
Journal:  J Neurosci Res       Date:  2015-01-29       Impact factor: 4.164

2.  Leptin stimulates neuropeptide Y and cocaine amphetamine-regulated transcript coexpressing neuronal activity in the dorsomedial hypothalamus in diet-induced obese mice.

Authors:  Shin J Lee; Saurabh Verma; Stephanie E Simonds; Melissa A Kirigiti; Paul Kievit; Sarah R Lindsley; Alberto Loche; M Susan Smith; Michael A Cowley; Kevin L Grove
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

3.  Maternal deprivation exacerbates the response to a high fat diet in a sexually dimorphic manner.

Authors:  Virginia Mela; Álvaro Llorente-Berzal; Francisca Díaz; Jesús Argente; María-Paz Viveros; Julie A Chowen
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

4.  Interaction between neonatal maternal deprivation and serum leptin levels on metabolism, pubertal development, and sexual behavior in male and female rats.

Authors:  Virginia Mela; Francisca Díaz; María Jesús Vázquez; Jesús Argente; Manuel Tena-Sempere; Maria-Paz Viveros; Julie A Chowen
Journal:  Biol Sex Differ       Date:  2016-01-11       Impact factor: 5.027

Review 5.  Sex and gender differences in developmental programming of metabolism.

Authors:  Laura Dearden; Sebastien G Bouret; Susan E Ozanne
Journal:  Mol Metab       Date:  2018-04-30       Impact factor: 7.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.